Grants and Contributions:
Title:
Development of the Actiphage technology for rapid and efficient diagnosis of mycobacterial infection in the Canadian setting
Agreement Number:
939035
Agreement Value:
$120,000.00
Agreement Date:
Dec 1, 2019 - Mar 26, 2021
Description:
PBD Bio has developed a substantially faster, more accurate and reliable method to detect the presence of live Mycobacterial infections. This project will validate the use of the technology in the Canadian setting and establish the base of Canadian operations.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Saskatoon, Saskatchewan, CA S7K 1M5
Reference Number:
172-2019-2020-Q4-939035
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
751747510
Recipient Type:
For-profit organization
Recipient's Legal Name:
PBD Biotech Canada Limited
Federal Riding Name:
Saskatoon West
Federal Riding Number:
47012
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
62151